Interview: Merck committed to investing, succeeding in China

BEIJING, July 27 (Xinhua) -- China is the second most important pharmaceuticals market in the world, and is "a market in which we have to be present and in which we have to succeed," according to Peter Guenter, CEO of Healthcare at Merck Group, Germany's leading science and technology company.

Speaking to Xinhua, Guenter said China is a country of great importance and enormous potential for the company, and expressed confidence that Merck will invest more in China in the future.